The Newcastle Cancer Centre Pharmacology Group (NCCPG) is a dedicated team of experienced researchers. We have a proven track record in running clinical pharmacology studies in an oncology setting.
We work in close collaboration with many organisations including:
- the CRUK Centre for Drug Development
- academic groups
- pharma and biotech companies conducting clinical pharmacology studies across various phases of clinical trials
We aim to develop novel and innovative pharmacokinetic and pharmacodynamic biomarker assays. This enables the analysis of clinical samples.
Our research has contributed to:
- development of new anticancer drugs
- introduction of new treatment guidelines
- development of an infant chemotherapy dosing guidance website (https://nccpg.ncl.ac.uk/)
- development of novel drug formulations in both adult and paediatric cancer settings
